Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001349991 | SCV001544361 | uncertain significance | Fanconi anemia | 2021-09-24 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with proline at codon 613 of the FANCB protein (p.Arg613Pro). The arginine residue is weakly conserved and there is a moderate physicochemical difference between arginine and proline. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with FANCB-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002486439 | SCV002781680 | uncertain significance | Fanconi anemia complementation group B; VACTERL association, X-linked, with or without hydrocephalus | 2021-10-22 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004692613 | SCV005192366 | uncertain significance | not provided | criteria provided, single submitter | not provided |